Impaired placentation
- First trimester screening program for preeclampsia and preterm delivery
- First trimester screening test for preeclampsia and premature delivery
- Immunohistochemical expression of NGF receptor (p-TRKA) in placental tissue of early-onset pre-eclampsia
- Maternal plasma nerve growth factor at 11 to 13 weeks as a novel angiogenic marker of pre-eclampsia
- Prediction of early pre-eclampsia by maternal characteristic, mean blood pressure and uterine artery Doppler
- Predictive model of small-for-gestational newborn without pre-eclampsia at 11+0 – 13+6 weeks
- Ultrasound examination of transient cerebral layers at 25 to 29 weeks’ gestation in severely FGR fetuses
- The Dresden Registry: Maternal Morbidity in hypertensive disorders in pregnancies
- The Dresden Registry: Fetal and neonatal outcome in hypertensive disorders in pregnancies
- Fetal aortic isthmus: Doppler a predictive marker for IUGR fetuses
- Amniotic fluid “sludge” as a risk factor for fetal growth restriction
- Ratio of MCA/UA doppler velocimetry and perinatal outcome in pregnancies beyond term
- Predictive value of mean arterial pressure in first trimester of pregnancy for risk of preeclampsia
- Identification of Small-for-Gestational-Age fetuses at risk of adverse perinatal outcome
- A study of the first and second trimester screening of preeclampsia and gestational hypertension
- Prediction of small for gestational age neonates by fetal biometry and uterine artery Doppler at 19-22 weeks
- First trimester prediction of fetal growth restriction in low risk pregnancies
- Association of preeclampsia with maternal mean platelet volume
- The effectiveness of the Barcelona fetal Medicine staging protocol in the management of IUGR
- Screening for spontaneous preterm delivery and preeclampsia in the first trimester in twins
- Characterization of immune patterns according to first trimester uterine artery Doppler
- Vascular and tissue Doppler parameters for the detection of a high risk IUGR fetus
- Uterine artery doppler pulsatility index at 11-14 weeks in ART pregnancies with egg-donation
- The role of angiogenic factors for first trimester screening of fetal growth restriction
- Placental growth factor in first trimester as a marker of adverse perinatal outcome
- An inflamation marker in preeclampsia: neutrophil to lymphocyte ratio
- A case of antenatal diagnosis of vasa praevia
- Prevention of placental insufficiency by acetylsalicylic acid and low molecular weight heparin
- Intake assay of angiogenic factors (sflt -1 / plgf) in the diagnosis and monitoring pre-eclampsia
- Maternal characteristics, fetal biometry and fetal Doppler indices at 28 weeks’ gestation
- Two cases of atypical presentation of severe PET in late pregnancy
- Role of uterine artery Doppler in predicting an impaired placentation for thrombophilic women
- Uterine artery Doppler in first and second trimesters as a “continuum” for LBW
- Behavior sFlt-1 / PlGF ratio in twin pregnancies with and without preeclampsia compared with singleton pregnancies
- Measurement of sFlt-1 / PlGF at 26 weeks for detection of early onset placental complications
- Usefulness of BOLD MRI to assess fetal response to maternal hyperoxigenation in IUGR and normal fetuses
- Prediction of preeclampsia by maternal ophthalmic artery doppler in the first and second trimester
- Prediction of PE by brachial artery flow-mediated dilatation in the three trimesters
- Fetal and placental tissue characterisation and the role of 3D and Doppler ultrasound in lung maturity
- Cell-free fetal DNA as a predictor for preeclampsia
- RCT: Comparison of 80 vs 160 mg of aspirin in pregnant women with previous history of preeclampsia
- Number of episodes of reduced fetal movements at term: association with adverse perinatal outcome
- Prediction of FGR by fetal biometry, uterine artery doppler and maternal demographic characteristics
- Prediction of stillbirth by fetal biometry, uterine artery doppler and maternal demographic characteristics
- Notch signaling pathway in late preterm and term placentas from pregnancies complicated by preeclampsia
- PAPPA, PAPPA-2 and PLAC-1 placental expression in pregnancies with fetal growth restriction
- The correlation of systemic inflammation markers in preeclampsia with cardiovascular risk
- The role of some angiogenesis markers in preeclampsia management
- Maternal serum oxidative stress markers and antioxidant enzyme levels in preeclampsia
- Comparison of short-term perinatal outcome of pregnancies according to umbilical artery Dopplers
- Placental ADAMTS-12 levels in the pathogenesis of preeclampsia and intrahepatic cholestasis of pregnancy
- Usefulness of the uterine artery doppler flow velocimetry at 20 weeks
- Doppler Modifications in Intrauterine Growth Restricted Fetuses: the DOMINO study
- Reproducibility of transabdominal and transvaginal Doppler flow of uterine arteries during the first trimester
- Cytokines as predictors in moderate and severe preeclampsia
- High first-trimester maternal serum β-human chorionic gonadotrofin and adverse pregnancy outcome
- Uterine artery pulsatility index in the first trimester in high risk population and adverse perinatal outcome
- Preeclampsia in twin pregnancies: impact of chorionicity and number of liveborn infants
- Impact of postnatal environmental enrichment in neurodevelopment in an animal model of IUGR
- Determination of nitric oxide concentration in placental tissue with Electron Paramagnetic Resonance
- Low first-trimester maternal serum pregnancy-associated plasma protein-A and adverse pregnancy outcome
- Vascular biopsy of the placenta using VOCAL2 ultrasound software in the prediction of IUGR
- Maternal serum copeptin, MR-proANP and procalcitonin levels at 11-13 weeks in the prediction of PE
- The impact of aspirin dose on the prevention of preeclampsia and IUGR
- Comparison of maternal and cord blood ischemia modified albumin levels in normal and PE pregnancies
- Influence of neurotransmitters on cerebral vascular response to severe hypoxia in ovine fetuses
- The risk of adverse pregnancy outcome in the setting of very low first trimester maternal PAPP-A levels
- Placental T2* in normal pregnancy and in pregnancies complicated by fetal growth restriction
- Comparing new and traditional definitions of fetal growth restriction: A retrospective analysis
- Screening for late placental dysfunction with uterine artery Doppler at 28-34 weeks
- Prediction model for pre-eclampsia using a combination of clinical biophysical and biochemical markers
- Detection of antenatal viral infection in normal and preeclampsia complicated pregnancy
- Effect of aspirin in the prevention of adverse pregnancy outcome in women
- Prognostic value of admission plasma glucose in preeclampsia and HELLP syndrome
- Early pregnancy maternal serum markers in the prediction of pre-eclampsia in twins
- Comparison of PAPP-A levels, Doppler ultrasound measurements and pregnancy results
- The expressions of B7-H1 and B7-H4 co-stimulatory molecules on dendritic cells in pre-eclampsia
- The expressions of apoptosis markers are altered in CD4+CD25+FoxP3+ T regulatory lymphocytes in PE
- Doppler velocimetry in preeclampsia and correlation with perinatal outcome
- Risk stratification for the SGA infant: is green top guideline 31 deliverable in a busy hospital setting?
- Fetal growth in spontaneous and IVF pregnancies: A prospective study
- Longitudinal changes in uterine, umbilical and fetal MCA Doppler indices in late onset small fetuses
- Circulating and myometrial markers of oxidative stress in pregnant women with fetal growth restriction
- Prediction of SGA by third-trimester VEGF, sFlt1 and PlGF